(Q35019017)

5 August 2017

Natalizumab and HSV meningitis (English)

1 reference

5 August 2017

1 reference

Erica Seiguer Shenoy

1

1 reference

5 August 2017

Eleftherios Mylonakis

series ordinal

2

1 reference

5 August 2017

Rocio M Hurtado

series ordinal

3

1 reference

5 August 2017

Nagagopal Venna

series ordinal

4

1 reference

5 August 2017

language of work or name

1 reference

13 April 2011

1 reference

5 August 2017

Journal of NeuroVirology

1 reference

5 August 2017

17

1 reference

5 August 2017

3

1 reference

5 August 2017

288-290

1 reference

https://scigraph.springernature.com/pub.10.1007/s13365-011-0027-4

5 August 2017

0 references

cites work

Alemtuzumab vs. interferon beta-1a in early multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105891

Neurological complications of herpes simplex virus type 2 infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105891

Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab*.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105891

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105891

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105891

Natalizumab for active Crohn's disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105891

A controlled trial of natalizumab for relapsing multiple sclerosis.

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS13365-011-0027-4

α4Integrins as Therapeutic Targets in Autoimmune Disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS13365-011-0027-4

10.1007/S13365-011-0027-4

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference

5 August 2017

1 reference